This research project is led by Paloma Boeck, a master’s student of human genomics and genetic counseling at Keck Graduate Institute, and is supervised by Emily Quinn, an associate program director and certified genetic counselor at Keck Graduate Institute. The goal of this study is to explore what information is considered most important to recently identified fragile X premutation carriers. This information can help educate health care providers regarding what information patients want to know more about.
About the Study
Who can participate?
To be in this study, you must be 18 years old or older, English-speaking, and you must have been identified as a fragile X premutation carrier anywhere between January 1, 2018, until the present.
What will happen in the study?
During this study, you will be asked to complete an online survey and you may be contacted for a follow up interview if you meet the eligibility criteria of the study. The online survey will focus on background information and how you found out that you were a fragile x premutation carrier. This survey will take about five minutes of your time.
After the survey you may be contacted for an interview. You will be contacted based on your choice, either a phone call or email, to schedule the interview. This interview will focus on what information you remember about your results, what was most important for you at the time of your results, how you were given your results, and what information you wanted to know more about. This interview will be through a communication program called Zoom where you can talk through a video or a call. The interview will take about one hour of your time.
What are the good things that can happen from this research?
This study will add to the growing body of research for fragile X premutation carriers.This study may also help genetic counselors direct information based on what patients find is most important to them.
What are the bad things that can happen from this research?
The risks that you run by taking part in this study are minimal. The risks include feeling uneasy while talking about your personal results, unusual inconvenience and/or sharing possibly damaging personal information. The risks will be controlled by removing your personal identifying information and securing information from the interview on a secure password protected device.
Will I be paid to participate in this study?
No, you will not be directly compensated for participating in this study.
Our Most Recent Opportunities
Study: UNC Brain Development Research Study of Infants with Fragile X Syndrome
UNC Chapel Hill is conducting a research study to learn about the early brain and behavioral development of infants with FXS to aid in the future development of better supports and treatments.
Conference Research Opportunity: Cincinnati Research & Treatment Center Biorepository
Researchers at Cincinnati Children’s Hospital Medical Center want to partner with you or your child to learn more about Fragile X. The Cincinnati Research & Treatment Center team will be conducting research in San Diego at the Town and Country Resort from July 12-14th, 2022 for International Fragile X Meeting attendees. All ages are welcome to participate.
BRIDGE Study: Brain Indicators of Development Growth
A longitudinal research study from The Wilkinson Lab at the Boston Children’s Hospital Labs of Cognitive Neuroscience to learn about how differences in brain activity affect learning, language, and behavior in Fragile X Syndrome.
Clinical Trial RECONNECT: ZYN002 Gel
This study will evaluate the efficacy and safety of ZYN002, a clear cannabidiol (CBD) gel that can be applied to the skin (called transdermal application) twice a day for the treatment of behavioral symptoms of Fragile X syndrome (FXS).
Study: Memory Game in Children with FXS
A study to learn about memory and memory development in children with Fragile X syndrome.
Focus Group: Parental Satisfaction with Fragile X Resources
A USC master’s program research study to learn about parents’ satisfaction with resources received when child is diagnosed with FXS.
Image by GraphicMama-team from Pixabay